191 related articles for article (PubMed ID: 17966394)
1. The enigmatic function of TREM-2 in osteoclastogenesis.
Colonna M; Turnbull I; Klesney-Tait J
Adv Exp Med Biol; 2007; 602():97-105. PubMed ID: 17966394
[TBL] [Abstract][Full Text] [Related]
2. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
3. Impaired differentiation of osteoclasts in TREM-2-deficient individuals.
Cella M; Buonsanti C; Strader C; Kondo T; Salmaggi A; Colonna M
J Exp Med; 2003 Aug; 198(4):645-51. PubMed ID: 12913093
[TBL] [Abstract][Full Text] [Related]
4. The signaling adapter protein DAP12 regulates multinucleation during osteoclast development.
Humphrey MB; Ogasawara K; Yao W; Spusta SC; Daws MR; Lane NE; Lanier LL; Nakamura MC
J Bone Miner Res; 2004 Feb; 19(2):224-34. PubMed ID: 14969392
[TBL] [Abstract][Full Text] [Related]
5. High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.
Faccio R; Zou W; Colaianni G; Teitelbaum SL; Ross FP
J Cell Biochem; 2003 Dec; 90(5):871-83. PubMed ID: 14624447
[TBL] [Abstract][Full Text] [Related]
6. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
[TBL] [Abstract][Full Text] [Related]
7. TREM-1, a negative regulator of human osteoclastogenesis.
Lee B; Kim JH; Jung JH; Kim TH; Ji JD
Immunol Lett; 2016 Mar; 171():50-9. PubMed ID: 26852644
[TBL] [Abstract][Full Text] [Related]
8. Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12.
Paradowska-Gorycka A; Jurkowska M
Hum Immunol; 2013 Jun; 74(6):730-7. PubMed ID: 23459077
[TBL] [Abstract][Full Text] [Related]
9. Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells.
Tessarz AS; Weiler S; Zanzinger K; Angelisová P; Horejsí V; Cerwenka A
J Immunol; 2007 Feb; 178(4):1991-9. PubMed ID: 17277102
[TBL] [Abstract][Full Text] [Related]
10. CSTA plays a role in osteoclast formation and bone resorption by mediating the DAP12/TREM2 pathway.
Wei R; Zhang L; Hu W; Wu J; Zhang W
Biochem Biophys Res Commun; 2022 Oct; 627():12-20. PubMed ID: 36007331
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
Humphrey MB; Nakamura MC
Clin Rev Allergy Immunol; 2016 Aug; 51(1):48-58. PubMed ID: 26573914
[TBL] [Abstract][Full Text] [Related]
12. TLT-1s, alternative transcripts of triggering receptor expressed on myeloid cell-like transcript-1 (TLT-1), Inhibits the triggering receptor expressed on myeloid cell-2 (TREM-2)-mediated signaling pathway during osteoclastogenesis.
Yoon SH; Lee YD; Ha J; Lee Y; Kim HH
J Biol Chem; 2012 Aug; 287(35):29620-6. PubMed ID: 22761415
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Siglec-15 in regulating RAP1/RAC signaling in cytoskeletal remodeling in osteoclasts mediated by macrophage colony-stimulating factor.
Kobayashi H; Terkawi MA; Ota M; Hasegawa T; Yamamoto T; Shimizu T; Sato D; Fujita R; Murakami T; Amizuka N; Iwasaki N; Takahata M
Bone Res; 2024 Jun; 12(1):35. PubMed ID: 38849345
[TBL] [Abstract][Full Text] [Related]
14. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.
Inui M; Kikuchi Y; Aoki N; Endo S; Maeda T; Sugahara-Tobinai A; Fujimura S; Nakamura A; Kumanogoh A; Colonna M; Takai T
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4816-21. PubMed ID: 19251634
[TBL] [Abstract][Full Text] [Related]
15. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha.
Sato N; Takahashi N; Suda K; Nakamura M; Yamaki M; Ninomiya T; Kobayashi Y; Takada H; Shibata K; Yamamoto M; Takeda K; Akira S; Noguchi T; Udagawa N
J Exp Med; 2004 Sep; 200(5):601-11. PubMed ID: 15353553
[TBL] [Abstract][Full Text] [Related]
16. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.
Paloneva J; Mandelin J; Kiialainen A; Bohling T; Prudlo J; Hakola P; Haltia M; Konttinen YT; Peltonen L
J Exp Med; 2003 Aug; 198(4):669-75. PubMed ID: 12925681
[TBL] [Abstract][Full Text] [Related]
17. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development.
Gingras MC; Lapillonne H; Margolin JF
Mol Immunol; 2002 Mar; 38(11):817-24. PubMed ID: 11922939
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.
Hamerman JA; Jarjoura JR; Humphrey MB; Nakamura MC; Seaman WE; Lanier LL
J Immunol; 2006 Aug; 177(4):2051-5. PubMed ID: 16887962
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes and the Dap12 adaptor are key regulators of osteoclast activation associated with gonadal failure.
Anginot A; Dacquin R; Mazzorana M; Jurdic P
PLoS One; 2007 Jul; 2(7):e585. PubMed ID: 17611620
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic insight into osteoclast differentiation in osteoimmunology.
Takayanagi H
J Mol Med (Berl); 2005 Mar; 83(3):170-9. PubMed ID: 15776286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
